Autor: |
Sai-Hong Ignatius Ou, MD PhD, Misako Nagasaka, MD |
Jazyk: |
angličtina |
Rok vydání: |
2020 |
Předmět: |
|
Zdroj: |
JTO Clinical and Research Reports, Vol 1, Iss 3, Pp 100048- (2020) |
Druh dokumentu: |
article |
ISSN: |
2666-3643 |
DOI: |
10.1016/j.jtocrr.2020.100048 |
Popis: |
ROS1 fusion–positive (ROS1+) NSCLC was discovered in 2007, the same year as the discovery of ALK-positive (ALK+) NSCLC but has trailed ALK+ NSCLC in terms of development. There seems to be a differential response to ROS1 inhibitors, which depend on fusion partners (CD74, SLC34A2, or SDC4); thus, knowledge of the fusion partners in ROS1+ NSCLC is important. To date (end of February 2020), we have identified 24 unique 5’ fusion partners of ROS1 in ROS1+ NSCLC from published literature and congress proceedings. Thus, we published this catalog for easy reference. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|